Almost every IPO prospectus you will ever open contains a paragraph about an over-allotment option, usually described in the same breath as a name that sounds like it belongs in a gardening catalogue: the greenshoe. Candidates preparing for equity capital markets interviews tend to memorise a one-line definition — "the option to sell 15% more stock" — and then fall apart the moment an interviewer asks the obvious follow-up: who actually owns that option, why does exercising it cost the syndicate nothing, and how on earth is a bank allowed to buy shares in a deal it just underwrote without that being market manipulation?

This article answers those questions properly. It explains what the greenshoe option is, how the syndicate short position that makes it work is deliberately created at allocation, what IPO stabilisation looks like in practice during the first weeks of trading, and where the legal boundaries sit. If you want to see the mechanics carried through with real numbers, work through the IPO Pricing and Stabilization case, which prices a German logistics listing from its order book and then runs the greenshoe through both an upside and a downside aftermarket scenario.

Where the name comes from, and what the option actually is

The term is an accident of history. The Green Shoe Manufacturing Company — a Massachusetts shoemaker, later Stride Rite — went public in 1963 with an underwriting agreement that contained a novel clause: the underwriters could require the company to issue additional shares beyond the agreed offering size, at the same price, for a limited window after listing. The structure worked, other banks copied it, and sixty years later the shoemaker's name is still what practitioners call the clause.

Stripped of the jargon, a greenshoe is a call option written by the issuer or by the selling shareholders in favour of the underwriting syndicate. It gives the syndicate the right, but never the obligation, to acquire additional shares — conventionally up to 15% of the base offering — at the final offer price, for a period that in Europe runs to 30 calendar days from the start of conditional trading. The 15% figure is market convention rather than law, and it is remarkably sticky: you will see it on Frankfurt, London, Amsterdam and New York listings alike.

Two structural variants matter. In a primary greenshoe, the additional shares are newly issued by the company, so exercising the option raises fresh capital and dilutes existing holders. In a secondary greenshoe, far more common in European deals, the shares come from existing shareholders — often borrowed from an anchor holder under a share lending agreement and then either bought outright or returned. A secondary greenshoe changes the free float without changing the share count, which is why it never shows up as dilution. If share count mechanics are new to you, the diluted share count case covers the treasury stock method and the difference between shares outstanding and shares available to trade.

The short position: why the syndicate creates a problem on purpose

Here is the part that most candidates miss, and it is the part that makes everything else make sense. The greenshoe is useless on its own. What gives it power is that the syndicate deliberately sells more shares than it can deliver.

Suppose the base offering is 20 million shares and the greenshoe is 15%, or 3 million shares. At allocation, the bookrunners do not allot 20 million shares. They allot the full 23 million, and they collect the offer price on all 23 million from investors. At closing, however, the issuer and the selling shareholders deliver only the 20 million base shares. The syndicate is therefore short 3 million shares, holding the cash it received for them.

That short position is not a mistake or a risk the bank forgot to hedge. It is the entire point. The syndicate now has exactly two ways to close it, and it gets to choose after it has seen how the stock trades:

  • Exercise the greenshoe and buy the 3 million shares from the issuer or selling shareholders at the offer price.
  • Buy 3 million shares in the open market and deliver those instead.

Because the option strike is the offer price, the choice is trivial once trading begins. If the stock trades above the offer price, the market route is more expensive, so the syndicate exercises. If the stock trades below, the market route is cheaper — and those market purchases are what the world sees as price support. The greenshoe is, in other words, a mechanism that makes stabilisation self-funding. The syndicate is not risking its own capital to prop up a struggling deal; it is covering a short it created, and it already holds the cash to do so.

This is also why the phrase "the greenshoe was exercised" is a signal, not an administrative footnote. Full exercise means the deal traded well and the bookrunners never needed to intervene. A lapsed greenshoe means the stabilisation manager spent the first month buying stock. Anyone reading the post-IPO announcements can tell which happened, and so can an interviewer.

What stabilisation looks like day to day

Once conditional trading opens, one named bank in the syndicate acts as stabilisation manager (the term "stabilisation agent" is used interchangeably). Its job during the stabilisation period is to stand in the market with a bid, absorbing what the industry calls flowback — the selling pressure from investors who received an allocation and want out quickly.

Flowback is a predictable feature of any large listing rather than a sign of failure. Some investors participate in IPOs specifically to flip; index funds that were not in the deal need to buy in, but only at rebalancing dates; and allocations that were scaled back in a hot book leave institutions holding positions smaller than they wanted, which they then trade around. Without a stabilising bid, the first few sessions of a new listing can be dominated by supply from investors who never intended to hold, producing a price move that says nothing about the business.

The stabilisation manager's bid is constrained in ways that matter. It may never be placed above the offer price. That single rule converts the offer price into a soft floor: as long as the syndicate still has a short position to cover, there is a buyer sitting at or just below the offer level. It is soft rather than hard because the ammunition is finite. A 15% greenshoe on a 20 million share deal buys exactly 3 million shares of support and no more. Once that short is fully covered, the bid disappears, which is why stocks that break issue frequently fall further a few weeks in, when the market works out that stabilisation has finished.

Partial outcomes are common and worth being able to describe. A stabilisation manager might cover 1.5 million shares in the market during a soft first fortnight, then watch the stock recover and exercise the greenshoe for the remaining 1.5 million. The two routes are not mutually exclusive; they are simply the cheaper option applied share by share. The broader sequence of events around this — kick-off, drafting, roadshow, bookbuilding, pricing, stabilisation and lock-up expiry — is laid out end to end in the IPO process case and in more narrative form in this walkthrough of every IPO stage from kick-off to lock-up expiry.

Why this is not market manipulation

Take a step back and the activity looks indefensible. A bank that has just sold a security to the public then goes into the market and buys that same security specifically to hold its price up. In almost any other context that would be a textbook manipulation offence.

It is permitted because regulators have written an explicit safe harbour around it. In the EU and the UK, the relevant framework is the Market Abuse Regulation together with the Commission Delegated Regulation on buy-back and stabilisation; in the United States, Regulation M performs the equivalent function. The policy reasoning is that a disorderly aftermarket in the days immediately after a listing harms the retail and institutional investors the rules exist to protect, and that a transparent, bounded stabilisation mechanism produces better price discovery than letting flowback run unchecked.

The safe harbour is conditional, and the conditions are the examinable part:

  • Advance disclosure. The prospectus must state that stabilisation may occur, name the stabilisation manager, and identify the maximum size of the over-allotment.
  • A defined window. Stabilisation may run for a maximum of 30 calendar days from the start of trading, and for a secondary offering the window is tied to the allotment date.
  • A price ceiling. Stabilising purchases may never be executed above the offer price.
  • A single actor. Only the designated stabilisation manager may stabilise, acting for the syndicate rather than on its own account.
  • Reporting. Transactions must be recorded and notified to the competent authority, and the outcome — including whether the greenshoe was exercised and to what extent — must be announced publicly at the end of the period.

Step outside any of those boundaries and the safe harbour falls away, leaving the conduct exposed to the general prohibition on manipulation. In interviews, being able to say "it is a conditional safe harbour under MAR, capped at 30 days and never above the offer price" is what separates a candidate who has read a prospectus from one who has read a definition.

How the greenshoe interacts with pricing and free float

The greenshoe does not exist in isolation from the pricing decision. Bookrunners size the base offering and set the price range with the shoe already in mind, because it gives them a lever to adjust final deal size after demand is known without reopening the terms.

Free float is the clearest consequence. Take a company with 80 million pre-IPO shares that issues 15 million new shares, so 95 million shares are outstanding after listing. If the full 23 million offered shares end up with public investors, the free float is 23.0 / 95.0, or roughly 24.2%. If the greenshoe lapses because the stock traded poorly, only 20 million shares are in public hands and the float drops to about 21.1%. That gap of three percentage points is not cosmetic: index providers apply free-float thresholds and free-float weighting, so a listing that misses the threshold for its target index misses out on a permanent, price-insensitive source of demand. Thinner float also means wider spreads and higher volatility, which feeds back into the multiple investors are willing to pay. The arithmetic behind deal size, float and shoe is worked through step by step in this guide to calculating IPO deal size, greenshoe and free float.

There is a second-order effect on valuation. Proceeds from a primary greenshoe reach the company's balance sheet and reduce net debt, which moves the bridge between enterprise value and equity value; proceeds from a secondary greenshoe go to the selling shareholders and leave the business untouched. If that distinction is not yet automatic for you, the difference between enterprise value and equity value is worth revisiting before an ECM interview, because bankers use the two terms interchangeably in conversation and precisely in models.

Where else the structure appears

Over-allotment and stabilisation are not unique to IPOs. Accelerated bookbuilds, follow-on offerings and convertible issues all use versions of the same structure, and the logic transfers directly: over-allot, create a short, then decide after the fact whether to exercise or to cover in the market.

The comparison that tends to come up in interviews is with alternative routes to a public listing. A SPAC transaction has no bookbuilding and no greenshoe in the conventional sense, because the pricing was fixed at the SPAC's own IPO and the de-SPAC merger relies on PIPE financing and redemption dynamics instead — which is precisely why de-SPAC share prices have historically been so volatile in the weeks after closing. A company running a dual-track process, weighing an IPO against an outright sale, is implicitly comparing a certain price from a trade buyer against an uncertain listing price that comes with a stabilisation mechanism attached but no guarantee of where the stock settles once the shoe is gone.

On the debt side, the equivalent conversation is about how new issues are priced against the secondary curve and how much of a new-issue concession the market demands. The interest rate sensitivity that drives all of it is covered in the bond basics case on duration, yield and price, which is the standard starting point for debt capital markets interviews.

What to be able to say in an interview

If an interviewer asks you to explain the greenshoe, the weak answer is a definition. The strong answer is a mechanism, delivered in four beats:

  1. The syndicate over-allots up to 15% more shares than the base deal and is therefore short at closing, holding cash against the short.
  2. It holds a call option, struck at the offer price, to buy those shares from the issuer or the selling shareholders.
  3. If the stock trades up it exercises; if the stock trades down it covers in the market instead, and those purchases are the stabilisation.
  4. The whole thing is permitted under a conditional regulatory safe harbour: disclosed in advance, capped at 30 days, never above the offer price, and reported afterwards.

Then be ready for the follow-ups that separate candidates. Who keeps the difference when the syndicate covers below the offer price? What happens to free float when the shoe lapses? Why do European deals favour secondary shoes over primary ones? Would a primary greenshoe change the post-IPO share count and, if so, by how much?

Those are exactly the questions the IPO Pricing and Stabilization case is built around, with a full order book to price from, a proceeds split between the company and the selling shareholders, and both aftermarket scenarios quantified. Work through it before your next ECM interview and the greenshoe stops being a piece of vocabulary and starts being something you can reason about under pressure.